ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,515Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 251

$466K Total Retail Price of All Prescriptions

Rank: 22 out of 251

315 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 315 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,569 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
LISINOPRIL 307 263 1 2
LEVOTHYROXINE SODIUM 270 257 2 3
OMEPRAZOLE 261 244 3 5
SIMVASTATIN 259 251 4 1
FUROSEMIDE 239 226 5 6
AMLODIPINE BESYLATE 188 188 6 4
HYDROCODONE-ACETAMINOPHEN 162 122 S3 7 18
METOPROLOL SUCCINATE 150 144 8 13
HYDROCHLOROTHIAZIDE 132 104 9 9
SERTRALINE HCL 128 94 10 22
GABAPENTIN 105 88 11 16
WARFARIN SODIUM 105 105 11 11
METOPROLOL TARTRATE 102 97 13 7
ATORVASTATIN CALCIUM 102 98 13 8
CITALOPRAM HBR 101 93 15 15
SPIRIVA 97 85 16 37
CYMBALTA 92 70 17 47
NAMENDA 92 89 17 44
LOSARTAN POTASSIUM 89 86 19 17
DONEPEZIL HCL 84 83 20 29
ATENOLOL 78 77 21 12
OXYCODONE HCL 74 48 S2 22 30
KLOR-CON M20 73 73 23 45
PREDNISONE 70 69 24 27
ROPINIROLE HCL 69 68 25 92
POLYETHYLENE GLYCOL 3350 68 68 26 40
ADVAIR DISKUS 67 53 27 25
PRAVASTATIN SODIUM 67 61 27 14
JANTOVEN 66 49 29 158
MELOXICAM 66 65 29 51
POTASSIUM CHLORIDE 65 65 31 33
MIRTAZAPINE 64 62 32 36
PANTOPRAZOLE SODIUM 63 52 33 20
SYNTHROID 60 45 34 71
TRAZODONE HCL 60 27 34 26
AZITHROMYCIN 59 54 36 59
QUETIAPINE FUMARATE 56 39 37 50
ALLOPURINOL 56 52 37 34
ZOLPIDEM TARTRATE 55 47 39 19
TAMSULOSIN HCL 50 45 40 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.